Please login to the form below

Not currently logged in
Email:
Password:

Edelman strengthens public affairs business

Brian Ellner was senior strategist behind New York’s marriage equality campaign
Edelman Brian Ellner

Edelmen has recruited an executive vice president and group head of public affairs.

Brian Ellner will lead Edelman's 35-strong New York public affairs group, reporting to Ron Guirguis, managing director of Edelman New York's corporate and public affairs practice.

Ellner was the senior strategist for the Human Rights Campaign's successful effort to win marriage equality in New York in 2011. Prior to that, he was a senior aide in the administration of Mayor Bloomberg, and has been a litigation associate at Paul Weiss and a litigation counsel at O'Melveny & Myers.

“Brian is an exciting addition to our team in New York and further demonstrates the firm's commitment to investing in and growing the public affairs practice,” said Guirguis.

“He's a proven leader who has successfully managed major public affairs campaigns in the city, the state and nationally.”

Ellner said he was thrilled to be joining at such an exciting time for New York.

“Edelman has set the gold standard for independence, creativity and digital innovation and I'm looking forward to being a part of an exceptionally talented and well-connected global public affairs team to help our clients navigate my hometown”, he added.

Edelman New York's corporate and public affairs practice is home to more than 170 professionals in public affairs, corporate communications, social purpose, employee engagement, technology and management consulting.

28th November 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics